ZimVie (ZIMV) to Release Earnings on Thursday

ZimVie (NASDAQ:ZIMVGet Free Report) is set to issue its quarterly earnings data after the market closes on Thursday, August 1st. ZimVie has set its FY 2024 guidance at 0.550-0.700 EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.

ZimVie (NASDAQ:ZIMVGet Free Report) last announced its quarterly earnings results on Wednesday, May 8th. The company reported $0.08 earnings per share for the quarter. The company had revenue of $118.20 million for the quarter. ZimVie had a positive return on equity of 2.01% and a negative net margin of 56.31%. During the same period in the prior year, the business posted $0.25 earnings per share.

ZimVie Stock Performance

Shares of ZIMV stock opened at $21.22 on Tuesday. ZimVie has a 52-week low of $6.52 and a 52-week high of $22.40. The company has a quick ratio of 2.23, a current ratio of 2.68 and a debt-to-equity ratio of 1.32. The stock has a market cap of $579.09 million, a PE ratio of -1.52 and a beta of 2.17. The business has a 50-day simple moving average of $17.82 and a 200-day simple moving average of $17.46.

Wall Street Analyst Weigh In

Separately, Needham & Company LLC reissued a “buy” rating and issued a $20.00 price target on shares of ZimVie in a report on Tuesday, June 25th.

Get Our Latest Analysis on ZIMV

ZimVie Company Profile

(Get Free Report)

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.

Featured Articles

Earnings History for ZimVie (NASDAQ:ZIMV)

Receive News & Ratings for ZimVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZimVie and related companies with MarketBeat.com's FREE daily email newsletter.